Cardiovalve
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Yahadut Canada St, Or Yehuda, Tel Aviv...Website
www.cardiovalve.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cardiovalve
Cardiovalve specializes in pioneering structural heart innovations, particularly through its flagship Cardiovalve system designed for transfemoral delivery. This novel transcatheter valve replacement system caters to both Mitral and Tricuspid anatomies, offering significant benefits such as minimal protrusion and a robust anchoring mechanism. The Cardiovalve system is currently restricted to research use, highlighting its focus on advanced medical solutions. Intended clients include healthcare professionals and institutions involved in cardiac care and research.Explore more
Cardiovalve Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cardiovalve your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cardiovalve had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Cardiovalve has new funding data
Check out if Cardiovalve is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Cardiovalve
Product Launch: Get notified when Cardiovalve launches new products
Earning: See what the market has to say on Cardiovalve recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Cardiovalve has recently received funding, and reach out quickly before it becomes old news!
Cardiovalve, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Cardiovalve
Find more new buyers
Company Profile Activity
Activity Insights
Cardiovalve is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cardiovalve is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cardiovalve.
Cardiovalve Tech Stack
A closer look at the technologies used by Cardiovalve
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Mergers & Acquisitions (M&A)
Cardiovalve News & Media
Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion
Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting. LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK) today announced that Cardiovalve has submitted the CE technical file for its transcatheter tricuspid...Cardiovalve Completes TARGET Study Enrollment for CE Registration Study for Tricuspid Valve Replacement
The Company Advances Toward European CE Mark Submission with 150 Patients Enrolled; On Track for 2027 Commercial Launch HANGZHOU, China, Oct. 25, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as the "Company") today announced the successful completion of patient enrollment in the Cardiovalve TARGET study for Transcatheter Tricuspid Valve Replacement (TTVR), with a total of 150 patients enrolled. The completion of enrollment marks a major milestone toward EuCourt Sides with Cardiovalve in Edwards patent spat
HANGZHOU, China, Aug. 5, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary Cardiovalve Ltd. ("Cardiovalve") against Edwards Lifesciences Corporation and Edwards...Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve
HANGZHOU, China, Jan. 25, 2022 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus MedTech, 2500.HK), a leading, innovative Chinese structural heart disease treatment company, announced its acquisition of 100% equity interest in Cardiovalve Ltd. (Cardiovalve), a pioneering transcatheter...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cardiovalve
Sign Up For FreeTo access detailed company insights
Cardiovalve specializes in pioneering structural heart innovations, particularly through its flagship Cardiovalve system designed for transfemoral delivery. This novel transcatheter valve replacement system caters to both Mitral and Tricuspid anatomies, offering significant benefits such as minimal protrusion and a robust anchoring mechanism. The C... Read More
